ERIC REEVES: Open Payments
NPI 1437698602 · VESTAL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,023 in 125 payments from 28 companies in 2025. Trend: 2023 $2,564 · 2024 $2,868 · 2025 $3,023
Food & beverage: $2,774Travel & lodging: $249
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 7 | $794 |
| ABBVIE INC. | 49 | $578 |
| EMD Serono, Inc. | 12 | $337 |
| Alexion Pharmaceuticals, Inc. | 4 | $116 |
| UCB, Inc. | 4 | $105 |
| Celgene Corporation | 5 | $99 |
| PFIZER INC. | 5 | $97 |
| Lundbeck LLC | 4 | $94 |
| SK Life Science, Inc. | 3 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
Products named: VNS Therapy, UBRELVY, QULIPTA, Mavenclad, ULTOMIRIS, Leqembi, ZEPOSIA, VYEPTI.
Industry payments across NY — which companies pay providers there.
